Ameriprise Financial Inc. lessened its holdings in HealthSouth Corporation (NYSE:HLS) by 14.2% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 404,472 shares of the company’s stock after selling 66,984 shares during the period. Ameriprise Financial Inc. owned about 0.41% of HealthSouth Corporation worth $19,580,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the company. WBI Investments Inc. raised its stake in shares of HealthSouth Corporation by 6.0% in the 2nd quarter. WBI Investments Inc. now owns 133,085 shares of the company’s stock valued at $6,442,000 after acquiring an additional 7,567 shares during the period. Symphony Asset Management LLC lifted its holdings in shares of HealthSouth Corporation by 4.4% during the 2nd quarter. Symphony Asset Management LLC now owns 6,228 shares of the company’s stock valued at $301,000 after acquiring an additional 261 shares in the last quarter. Riverhead Capital Management LLC boosted its position in HealthSouth Corporation by 60.6% during the 2nd quarter. Riverhead Capital Management LLC now owns 5,462 shares of the company’s stock worth $264,000 after purchasing an additional 2,062 shares during the period. Alliancebernstein L.P. boosted its position in HealthSouth Corporation by 22.8% during the 2nd quarter. Alliancebernstein L.P. now owns 187,744 shares of the company’s stock worth $9,087,000 after purchasing an additional 34,890 shares during the period. Finally, TimesSquare Capital Management LLC purchased a new stake in HealthSouth Corporation during the 2nd quarter worth $37,868,000. 93.04% of the stock is currently owned by institutional investors and hedge funds.

HealthSouth Corporation (NYSE HLS) opened at 46.35 on Monday. The firm has a market cap of $4.58 billion, a price-to-earnings ratio of 16.89 and a beta of 0.58. HealthSouth Corporation has a one year low of $36.97 and a one year high of $49.71. The firm has a 50-day moving average of $44.26 and a 200-day moving average of $44.95.

HealthSouth Corporation (NYSE:HLS) last issued its quarterly earnings data on Monday, July 31st. The company reported $0.71 EPS for the quarter, beating the Zacks’ consensus estimate of $0.68 by $0.03. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The business had revenue of $981.30 million for the quarter, compared to analyst estimates of $976.46 million. During the same quarter in the prior year, the firm posted $0.69 EPS. The firm’s revenue for the quarter was up 6.6% on a year-over-year basis. Analysts anticipate that HealthSouth Corporation will post $2.71 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Monday, October 2nd will be issued a $0.25 dividend. This is a positive change from HealthSouth Corporation’s previous quarterly dividend of $0.24. This represents a $1.00 annualized dividend and a yield of 2.16%. The ex-dividend date of this dividend is Friday, September 29th. HealthSouth Corporation’s payout ratio is 36.76%.

In other HealthSouth Corporation news, CEO Mark J. Tarr sold 22,625 shares of the company’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $43.00, for a total transaction of $972,875.00. Following the completion of the sale, the chief executive officer now owns 283,134 shares of the company’s stock, valued at $12,174,762. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.60% of the stock is currently owned by insiders.

HLS has been the subject of several recent research reports. KeyCorp initiated coverage on HealthSouth Corporation in a research report on Thursday, June 15th. They issued a “sector weight” rating on the stock. ValuEngine cut HealthSouth Corporation from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Zacks Investment Research downgraded HealthSouth Corporation from a “buy” rating to a “hold” rating in a research report on Tuesday, August 15th. BidaskClub raised HealthSouth Corporation from a “sell” rating to a “hold” rating in a research report on Saturday, June 17th. Finally, Royal Bank Of Canada reaffirmed a “buy” rating and issued a $53.00 target price on shares of HealthSouth Corporation in a research report on Wednesday, July 5th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $49.71.

TRADEMARK VIOLATION WARNING: This piece was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright laws. The correct version of this piece can be read at https://www.watchlistnews.com/ameriprise-financial-inc-sells-66984-shares-of-healthsouth-corporation-hls/1602426.html.

About HealthSouth Corporation

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Institutional Ownership by Quarter for HealthSouth Corporation (NYSE:HLS)

Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.